Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
AstraZeneca
Moodys
McKesson
Colorcon

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nepicastat

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Nepicastat?

Nepicastat is an investigational drug.

There have been 4 clinical trials for Nepicastat. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Biotie Therapies Inc., Ralph H. Johnson VA Medical Center, and National Institute on Drug Abuse (NIDA).

Recent Clinical Trials for Nepicastat
TitleSponsorPhase
A Multi-Center Trial of Nepicastat for Cocaine DependenceNational Institute on Drug Abuse (NIDA)Phase 2
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF VeteransBaylor College of MedicinePhase 2
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF VeteransBiotie Therapies Inc.Phase 2

See all Nepicastat clinical trials

Clinical Trial Summary for Nepicastat

Top disease conditions for Nepicastat
Top clinical trial sponsors for Nepicastat

See all Nepicastat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
McKesson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.